Selected research
Industry Growth & Trends
Global Skin Active Delivery System Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Skin Active Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Skin Active Delivery System market include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Skin Active Delivery System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Skin Active Delivery System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Skin Active Delivery System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Skin Active Delivery System.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Skin Active Delivery System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Skin Active Delivery System Market by Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Corium
Nitto
Valeritas
Nanopass Technologies
TheraJect, Inc
Vaxxas
Microdermics
Lohmann Therapie-Systeme AG
BASF
3M
Evonik Personal Care
Vantage Personal Care
Minerals Technologies
Bicosome
Skin Active Delivery System Segment by Type
Microcapsules
Base Oil
Microneedle Technology
Skin Active Delivery System Segment by Application
Drug
Cosmetic
Skin Active Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Active Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Active Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Active Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Skin Active Delivery System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Microcapsules
- Base Oil
- Microneedle Technology
Applications
- Drug
- Cosmetic
Companies covered
- KINDEVA
- Zosano Pharma
- Becton-Dickinson(BD)Technologies
- Corium
- Nitto
- Valeritas
- Nanopass Technologies
- TheraJect, Inc
- Vaxxas
- Microdermics
- Lohmann Therapie-Systeme AG
- BASF
- 3M
- Evonik Personal Care
- Vantage Personal Care
- Minerals Technologies
- Bicosome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Skin Active Delivery System Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Skin Active Delivery System Market Size by Region (2021-2032)
- 1.4.1 Global Skin Active Delivery System Market Size by Region (2021-2026)
- 1.4.2 Global Skin Active Delivery System Market Size by Region (2027-2032)
- 1.5 Key Regions Skin Active Delivery System Market Size (2021-2032)
- 1.5.1 North America Skin Active Delivery System Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Skin Active Delivery System Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Skin Active Delivery System Market Size Growth Rate (2021-2032)
- 1.5.4 South America Skin Active Delivery System Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Skin Active Delivery System Market Size Growth Rate (2021-2032)
2 Skin Active Delivery System Market by Type
- 2.1 Type Introduction
- 2.1.1 Microcapsules
- 2.1.2 Base Oil
- 2.1.3 Microneedle Technology
- 2.2 Global Skin Active Delivery System Market Size by Type
- 2.2.1 Global Skin Active Delivery System Market Size Overview by Type (2021-2032)
- 2.2.2 Global Skin Active Delivery System Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Skin Active Delivery System Market Size Forecasted by Type (2027-2032)
- 2.3 Global Skin Active Delivery System Market Size by Regions
- 2.3.1 North America Skin Active Delivery System Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Skin Active Delivery System Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Skin Active Delivery System Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Skin Active Delivery System Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Skin Active Delivery System Market Size Breakdown by Type (2021-2026)
3 Skin Active Delivery System Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug
- 3.1.2 Cosmetic
- 3.2 Global Skin Active Delivery System Market Size by Application
- 3.2.1 Global Skin Active Delivery System Market Size Overview by Application (2021-2032)
- 3.2.2 Global Skin Active Delivery System Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Skin Active Delivery System Market Size Forecasted by Application (2027-2032)
- 3.3 Global Skin Active Delivery System Market Size by Regions
- 3.3.1 North America Skin Active Delivery System Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Skin Active Delivery System Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Skin Active Delivery System Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Skin Active Delivery System Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Skin Active Delivery System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Skin Active Delivery System Industry Trends
- 4.2 Skin Active Delivery System Industry Drivers
- 4.3 Skin Active Delivery System Industry Opportunities and Challenges
- 4.4 Skin Active Delivery System Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Skin Active Delivery System Revenue (2021-2026)
- 5.2 Global Skin Active Delivery System Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Skin Active Delivery System Key Company Headquarters & Area Served
- 5.4 Global Skin Active Delivery System Company, Product Type & Application
- 5.5 Global Skin Active Delivery System Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Skin Active Delivery System Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Skin Active Delivery System Players Market Share by Revenue in 2025
- 5.6.3 2025 Skin Active Delivery System Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 KINDEVA
- 6.1.1 KINDEVA Company Information
- 6.1.2 KINDEVA Business Overview
- 6.1.3 KINDEVA Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 KINDEVA Skin Active Delivery System Product Portfolio
- 6.1.5 KINDEVA Recent Developments
- 6.2 Zosano Pharma
- 6.2.1 Zosano Pharma Company Information
- 6.2.2 Zosano Pharma Business Overview
- 6.2.3 Zosano Pharma Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Zosano Pharma Skin Active Delivery System Product Portfolio
- 6.2.5 Zosano Pharma Recent Developments
- 6.3 Becton-Dickinson(BD)Technologies
- 6.3.1 Becton-Dickinson(BD)Technologies Company Information
- 6.3.2 Becton-Dickinson(BD)Technologies Business Overview
- 6.3.3 Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio
- 6.3.5 Becton-Dickinson(BD)Technologies Recent Developments
- 6.4 Corium
- 6.4.1 Corium Company Information
- 6.4.2 Corium Business Overview
- 6.4.3 Corium Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Corium Skin Active Delivery System Product Portfolio
- 6.4.5 Corium Recent Developments
- 6.5 Nitto
- 6.5.1 Nitto Company Information
- 6.5.2 Nitto Business Overview
- 6.5.3 Nitto Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Nitto Skin Active Delivery System Product Portfolio
- 6.5.5 Nitto Recent Developments
- 6.6 Valeritas
- 6.6.1 Valeritas Company Information
- 6.6.2 Valeritas Business Overview
- 6.6.3 Valeritas Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Valeritas Skin Active Delivery System Product Portfolio
- 6.6.5 Valeritas Recent Developments
- 6.7 Nanopass Technologies
- 6.7.1 Nanopass Technologies Company Information
- 6.7.2 Nanopass Technologies Business Overview
- 6.7.3 Nanopass Technologies Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Nanopass Technologies Skin Active Delivery System Product Portfolio
- 6.7.5 Nanopass Technologies Recent Developments
- 6.8 TheraJect, Inc
- 6.8.1 TheraJect, Inc Company Information
- 6.8.2 TheraJect, Inc Business Overview
- 6.8.3 TheraJect, Inc Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 TheraJect, Inc Skin Active Delivery System Product Portfolio
- 6.8.5 TheraJect, Inc Recent Developments
- 6.9 Vaxxas
- 6.9.1 Vaxxas Company Information
- 6.9.2 Vaxxas Business Overview
- 6.9.3 Vaxxas Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Vaxxas Skin Active Delivery System Product Portfolio
- 6.9.5 Vaxxas Recent Developments
- 6.10 Microdermics
- 6.10.1 Microdermics Company Information
- 6.10.2 Microdermics Business Overview
- 6.10.3 Microdermics Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Microdermics Skin Active Delivery System Product Portfolio
- 6.10.5 Microdermics Recent Developments
- 6.11 Lohmann Therapie-Systeme AG
- 6.11.1 Lohmann Therapie-Systeme AG Company Information
- 6.11.2 Lohmann Therapie-Systeme AG Business Overview
- 6.11.3 Lohmann Therapie-Systeme AG Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio
- 6.11.5 Lohmann Therapie-Systeme AG Recent Developments
- 6.12 BASF
- 6.12.1 BASF Company Information
- 6.12.2 BASF Business Overview
- 6.12.3 BASF Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 BASF Skin Active Delivery System Product Portfolio
- 6.12.5 BASF Recent Developments
- 6.13 3M
- 6.13.1 3M Company Information
- 6.13.2 3M Business Overview
- 6.13.3 3M Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 3M Skin Active Delivery System Product Portfolio
- 6.13.5 3M Recent Developments
- 6.14 Evonik Personal Care
- 6.14.1 Evonik Personal Care Company Information
- 6.14.2 Evonik Personal Care Business Overview
- 6.14.3 Evonik Personal Care Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Evonik Personal Care Skin Active Delivery System Product Portfolio
- 6.14.5 Evonik Personal Care Recent Developments
- 6.15 Vantage Personal Care
- 6.15.1 Vantage Personal Care Company Information
- 6.15.2 Vantage Personal Care Business Overview
- 6.15.3 Vantage Personal Care Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Vantage Personal Care Skin Active Delivery System Product Portfolio
- 6.15.5 Vantage Personal Care Recent Developments
- 6.16 Minerals Technologies
- 6.16.1 Minerals Technologies Company Information
- 6.16.2 Minerals Technologies Business Overview
- 6.16.3 Minerals Technologies Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Minerals Technologies Skin Active Delivery System Product Portfolio
- 6.16.5 Minerals Technologies Recent Developments
- 6.17 Bicosome
- 6.17.1 Bicosome Company Information
- 6.17.2 Bicosome Business Overview
- 6.17.3 Bicosome Skin Active Delivery System Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Bicosome Skin Active Delivery System Product Portfolio
- 6.17.5 Bicosome Recent Developments
7 North America
- 7.1 North America Skin Active Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Skin Active Delivery System Market Size by Country (2021-2026)
- 7.3 North America Skin Active Delivery System Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Skin Active Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Skin Active Delivery System Market Size by Country (2021-2026)
- 8.3 Europe Skin Active Delivery System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Skin Active Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Skin Active Delivery System Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Skin Active Delivery System Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Skin Active Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Skin Active Delivery System Market Size by Country (2021-2026)
- 10.3 South America Skin Active Delivery System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Skin Active Delivery System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Skin Active Delivery System Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Skin Active Delivery System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst